| 摘要 |
<p>The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (∀200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.</p> |
| 申请人 |
CORNELLI, UMBERTO;DE AMBROSI, LUIGI;LORENS, STANLEY;FAREED, JAWED;LEE, JOHN;HANIN, ISRAEL;MERVIS, RONALD |
发明人 |
CORNELLI, UMBERTO;DE AMBROSI, LUIGI;LORENS, STANLEY;FAREED, JAWED;LEE, JOHN;HANIN, ISRAEL;MERVIS, RONALD |
